Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

SGI-DNA touts its automated gene printer for coronavirus vaccine development

By Sean Whooley | March 24, 2020

Synthetic biology company SGI-DNA is touting its efforts to accelerate research in the creation of vaccines for SARS-CoV-2, the virus causing the COVID-19 pandemic.

The San Diego-based company said in a news release last month that it built the genes thought to be critical to developing successful vaccines against the virus and made those tools available as genomic assemblies and DNA libraries.

Using the company’s BioXp 3200 automated gene printing system that was used to create vaccines and therapeutics against the H7N9 bird flu in 2013, SGI-DNA hopes that it can provide its partners with a vehicle to develop vaccines for the coronavirus that has caused widespread crisis across the globe.

SGI-DNA is donating $50,000 toward the purchase of a BioXp 3200 system for researchers focused on the coronavirus outbreak, as well as other pandemics. The company’s goal is for the speed of its science to outpace the spread of the virus, according to SGI-DNA chief technology officer Dan Gibson.

“There is zero time to waste, which is why we’ve built resources for our partners and are co-funding purchases of the BioXp 3200 for anyone working on a vaccine or therapeutic treatment,” SGI-DNA CEO Todd Nelson said in the news release. “Researchers need synthetic DNA and RNA, which the BioXp 3200 can provide in as little as eight hours. We simply don’t have ‘six to eight weeks, or longer’ to wait.”


Filed Under: Genomics/Proteomics, Infectious Disease
Tagged With: coronavirus, covid-19, SGI-DNA
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Seer
How Seer aims to remove technological barriers to studying the proteome
DNA Script SYNTAX
DNA Script raises $165M Series C for DNA printing platform
DNA Script SYNTAX
DNA Script launches a benchtop DNA printer
DNA
Unraveling the promise of genetics for treating progressive illnessĀ 

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50